Clinical Trials Logo

Adnexal Torsion clinical trials

View clinical trials related to Adnexal Torsion.

Filter by:
  • None
  • Page 1

NCT ID: NCT06324565 Recruiting - Adnexal Torsion Clinical Trials

Role of Preoperative D-dimer Levels in the Diagnosis of Adnexal Torsion

Start date: January 13, 2022
Phase:
Study type: Observational

Adnexal torsion is the fifth most common gynecologic emergency. Thirty percent of all cases of adnexal torsion occur in females younger than 20 years. Approximately 5 of 100,000 females aged 1-20 years are affected, with girls older than 10 years at increased risk because of hormonal influences and gonadal growth that result in an increased frequency of physiologic and pathologic masses. The most common clinical symptom of torsion is sudden-onset abdominal pain that is intermittent, non-radiating, and associated with nausea and vomiting in 62% and 67% of cases respectively. Moreover, abdominal tenderness is a clinical sign which is reported in up to 88% of patients with adnexal torsion. None of the following tests are useful in the diagnosis of adnexal torsion: leukocytosis, pyuria, C-reactive protein, and erythrocyte sedimentation rate. Actually, transabdominal ultrasonography is the imaging modality of choice with a sensitivity of 92% and specificity of 96% in detecting adnexal torsion. A second-line imaging tool in the diagnosis of adnexal torsion is magnetic resonance, which may require a sedation in selected cases. Consequently, there are no clinical or imaging criteria sufficient to confirm the preoperative diagnosis of adnexal torsion to date. Therefore, patients with a clinical suspicion for adnexal torsion should undergo emergent diagnostic laparoscopy.

NCT ID: NCT05060120 Recruiting - Adnexal Torsion Clinical Trials

Biomarker Panel in Ovarian Torsion

Start date: September 12, 2021
Phase:
Study type: Observational

The overall goal of the project is to find a panel of novel biomarkers for early detection of ovarian torsion.

NCT ID: NCT04522219 Terminated - Adnexal Torsion Clinical Trials

Contribution of Contrast Enhanced Ultrasound in the Diagnosis of Adnexal Torsion

AGATA
Start date: April 13, 2021
Phase: Phase 3
Study type: Interventional

Clinical diagnosis of adnexal torsion is difficult because the symptomatology is dominated by abrupt onset pelvic pain, an aspecific sign which does not allow a diagnosis of certainty to be made. To confirm the diagnosis, the reference examination is pelvic ultrasound with Doppler flow analysis. However, its intake is low, its sensitivity varies from 46 to 73% depending on the studies. Other imaging techniques have been considered, such as MRI, with a sensitivity far superior to ultrasound, but its difficult accessibility, in particular in the context of an emergency, makes it unusable in clinical practice. The use of ultrasound with the injection of an ultrasound contrast agent, strict intravascular, seems to be an interesting technique to assess the perfusion parameters of the ovary and improve the diagnostic sensitivity of the adnexal torsion. Its interest has already been demonstrated in the diagnosis of testicular torsion in animals but to date, no study has evaluated its contribution in adnexal torsion.

NCT ID: NCT01659489 Recruiting - Laparoscopy Clinical Trials

ADnexal TOrsion Markers Study

ATOMS
Start date: August 2012
Phase: N/A
Study type: Observational

Adnexal torsion , is a severe, though uncommon gynecological emergency, with a prevalence of 2.7-3%. The need for prompt diagnosis and treatment in order to save ovarian tissue has been realized a long time ago. A marker that will aid in the diagnosis of torsion and prevent missed diagnosis and unecessary loss of ovarian tissue, while not increasing the rate of unecessary laparoscopic interventions is much needed. To our knowledge, such marker has not been found. The purpose of this study is to find a marker using blood/serum from patients undergoing laparoscopy for suspected ovarian torsion